Correlation Between Bicycle Therapeutics and Adagene
Can any of the company-specific risk be diversified away by investing in both Bicycle Therapeutics and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bicycle Therapeutics and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bicycle Therapeutics and Adagene, you can compare the effects of market volatilities on Bicycle Therapeutics and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bicycle Therapeutics with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bicycle Therapeutics and Adagene.
Diversification Opportunities for Bicycle Therapeutics and Adagene
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Bicycle and Adagene is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Bicycle Therapeutics and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Bicycle Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bicycle Therapeutics are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Bicycle Therapeutics i.e., Bicycle Therapeutics and Adagene go up and down completely randomly.
Pair Corralation between Bicycle Therapeutics and Adagene
Given the investment horizon of 90 days Bicycle Therapeutics is expected to generate 0.72 times more return on investment than Adagene. However, Bicycle Therapeutics is 1.39 times less risky than Adagene. It trades about 0.01 of its potential returns per unit of risk. Adagene is currently generating about -0.03 per unit of risk. If you would invest 2,083 in Bicycle Therapeutics on September 3, 2024 and sell it today you would lose (43.00) from holding Bicycle Therapeutics or give up 2.06% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Bicycle Therapeutics vs. Adagene
Performance |
Timeline |
Bicycle Therapeutics |
Adagene |
Bicycle Therapeutics and Adagene Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bicycle Therapeutics and Adagene
The main advantage of trading using opposite Bicycle Therapeutics and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bicycle Therapeutics position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.Bicycle Therapeutics vs. Ideaya Biosciences | Bicycle Therapeutics vs. AnaptysBio | Bicycle Therapeutics vs. MeiraGTx Holdings PLC | Bicycle Therapeutics vs. Keros Therapeutics |
Adagene vs. DiaMedica Therapeutics | Adagene vs. Lyra Therapeutics | Adagene vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |